Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | ||
|---|---|---|---|---|---|
| 1 | 2 | 3 | |||
| Rash | very rare | x | x | x | |
| Hypersensitivity | very rare | x | x | x | |
| Hypertrichosis | very rare | x | x | x | |
| Opportunistic infection | very rare | x | x | ||
| Pruritus | very rare | x | x | ||
| Erythema | very rare | x | x | x | |
| Urticaria | very rare | x | x | ||
| Skin atrophy | very rare | x | x | x | |
| Allergic contact dermatitis | very rare | x | x | ||
| Infection | x | x | |||
| Contusion | x | ||||
| Endocrine disorder | x | x | |||
| Glaucoma | x | x | |||
| Glycosuria | x | x | |||
| Hair disorder | x | ||||
| Hyperglycaemia | x | x | |||
| Hypertension | x | x | |||
| Immune system disorder | x | x | |||
| Obesity | x | x | |||
| Osteoporosis | x | x | |||
| Rosacea | x | ||||
| Telangiectasia | x | x | |||
| Weight increased | x | x | |||
| Cataract | x | x | |||
| Growth retardation | x | x | |||
| Skin striae | x | ||||
| Unspecified disorder of skin and subcutaneous tissue | x | x | |||
| Secondary adrenocortical insufficiency | x | ||||
| Central obesity | x | x | |||
| Cushingoid | x | x | |||
| Atrophy | x | ||||
| Secondary infection | x | ||||
| Infestation NOS | x | x | |||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |